| scholarly article | Q13442814 |
| P50 | author | Adriana Maria Kakehasi | Q41556128 |
| P2093 | author name string | Dário Alves da Silva Costa | |
| Cristina Costa Duarte Lanna | |||
| Wilson Campos Tavares | |||
| Lílian Santuza Santos Porto | |||
| P2860 | cites work | Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score | Q24817087 |
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Q26859134 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Correlation of anti-cyclic citrullinated antibody with hand joint erosion score in rheumatoid arthritis patients | Q33893960 | ||
| Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study | Q33996117 | ||
| 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q34130671 | ||
| Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides | Q34569421 | ||
| Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial | Q35249589 | ||
| Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage | Q35552357 | ||
| Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations | Q35553712 | ||
| Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). | Q35554508 | ||
| Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). | Q35554533 | ||
| Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression | Q35555003 | ||
| Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis | Q35555021 | ||
| Prognostic laboratory markers of joint damage in rheumatoid arthritis | Q35555179 | ||
| Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis | Q35605524 | ||
| Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis | Q35808002 | ||
| An overview of commonly used radiographic scoring methods in rheumatoid arthritis clinical trials. | Q37781735 | ||
| Association of anticyclic citrullinated peptide antibodies with extra-articular manifestations, gender, and tabagism in rheumatoid arthritis patients from southern Brazil | Q37845720 | ||
| Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity | Q39295708 | ||
| Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state | Q39711494 | ||
| Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. | Q41824468 | ||
| Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids | Q42603691 | ||
| The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis | Q42631739 | ||
| A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination | Q42676934 | ||
| Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. | Q43073143 | ||
| Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity | Q43784954 | ||
| The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years | Q44972131 | ||
| Relation of rheumatoid factor and anti-cyclic citrullinated peptide antibody with disease activity in rheumatoid arthritis: cross-sectional study | Q46620150 | ||
| Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. | Q50545423 | ||
| Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. | Q50747871 | ||
| Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan. | Q51155261 | ||
| High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. | Q51752129 | ||
| Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: A magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients | Q56419586 | ||
| Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression | Q56420367 | ||
| P433 | issue | 1 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 15-22 | |
| P577 | publication date | 2015-12-02 | |
| P1433 | published in | Revista brasileira de reumatologia | Q27727294 |
| P1476 | title | Anti-CCP antibodies are not a marker of severity in established rheumatoid arthritis: a magnetic resonance imaging study. | |
| P478 | volume | 57 |
Search more.